Current Report Filing (8-k)
November 16 2020 - 4:44PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section
13 or 15(d) of the Securities Exchange Act of 1934
Date of Report
(Date of earliest event reported): November 16, 2020
NEMAURA
MEDICAL INC.
(Exact name of
registrant as specified in its charter)
Nevada
|
|
001-38355
|
|
46-5027260
|
(State
or other jurisdiction of
incorporation
or organization)
|
|
(Commission
File
Number)
|
|
(I.R.S.
Employer
Identification
Number)
|
57
West 57th Street
Manhattan,
NY
|
|
10019
|
(Address of principal executive offices)
|
|
(Zip Code)
|
|
|
|
Registrant’s telephone number, including area code:
|
|
(646) 416-8000
|
|
|
|
N/A
|
(Former name or former address, if changed since
last report)
|
Check the appropriate
box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[_]
|
Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
|
|
|
[_]
|
Soliciting material pursuant to Rule 14a-12 under the Exchange
Act (17 CFR 240.14a-12)
|
|
|
[_]
|
Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
[_]
|
Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to
Section 12(b) of the Act:
Title of each
class
|
|
Trading Symbol(s)
|
|
Name of each
exchange on which registered
|
Common Stock
|
|
NMRD
|
|
The Nasdaq Stock Market LLC
|
Indicate by
check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth
company [_]
If an emerging
growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with
any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. [_]
Item 8.01. Other Events.
On November
16, 2020, Nemaura Medical Inc. (the “Company”) issued a press release regarding certain business updates and financial
results for the fiscal quarter ended September 30, 2020. The press release is attached hereto as Exhibit 99.1 and, except with
regard to the websites referenced therein, incorporated herein by reference.
Item 9.01.
Financial Statements and Exhibits.
(d) Exhibits.
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Dated: November 16, 2020
|
NEMAURA MEDICAL INC.
|
|
|
|
By:
|
/s/ Dewan F. H. Chowdhury
|
|
Name:
Title:
|
Dewan F. H. Chowdhury
Chief Executive Officer
|
Nemaura Medical (NASDAQ:NMRD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Nemaura Medical (NASDAQ:NMRD)
Historical Stock Chart
From Sep 2023 to Sep 2024